Skip to main content
. Author manuscript; available in PMC: 2016 Mar 1.
Published in final edited form as: Stroke. 2015 Jan 22;46(3):757–761. doi: 10.1161/STROKEAHA.114.007634

Table 4.

Periprocedural and 4-year outcomes

Peri-procedural endpoints
Patch
# events
(rate ±
SEM)
No Patch
# events
(rate ±
SEM)
Hazard Ratio
for Patch vs
No Patch
(95% CI)*
P-
value
Hazard Ratio for
Patch vs No
Patch (95% CI)
P-
value
MI 19 (2.5±0.6) 6 (1.8±0.7) 1.46 (0.58,3.68) 0.43 1.07 (0.28, 3.99) 0.93
Stroke 9 (1.2±0.4) 13 (4.0±1.1) 0.35 (0.15,0.82) 0.02 1.58 (0.33, 7.58) 0.57
Stroke and death 9 (1.2±0.4) 13 (4.0±1.1) 0.35 (0.15,0.82) 0.02 1.58 (0.33,7.58) 0.57
Primary endpoint 28 (3.7±0.7) 18 (5.5±1.3) 0.74 (0.41,1.35) 0.33 1.26 (0.45, 3.56) 0.66

Four-year endpoints

Stroke 22 (3.5±0.8) 20 (6.6±1.5) 0.54 (0.29,0.99) 0.047 1.23 (0.42,3.63) 0.71
Stroke and death 22 (3.5±0.8) 20 (6.6±1.5) 0.54 (0.29,0.99) 0.046 1.23 (0.42,3.63) 0.71
Primary endpoint 40 (5.9±0.9) 25 (8.1±1.6) 0.76 (0.46, 1.26) 0.29 1.13 (0.49, 2.63) 0.08
*

adjusted for symptomatic status

adjusted for symptomatic status and surgeon board specialty